Steroidsupply

Local Anesthetic Drugs Lidocaine / Xylocaine CAS 137-58-6 fo

May 21st, 2017
50
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 1.67 KB | None | 0 0
  1. Local Anesthetic Drugs Lidocaine / Xylocaine CAS 137-58-6 for Reducing Pain
  2. Lidocaine Description:
  3. Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.
  4.  
  5. Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated.
  6.  
  7. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.
  8.  
  9. lidocaine Spec.
  10. Product Name: Linocaine Base
  11. Synonyms: Linocaine
  12. CAS No.: 137-58-6
  13. EINECS No.: 205-302-8
  14. Molecular formula: C14H22N2O
  15. Molecular weight: 234.34
  16. Density: 1.026 g/cm3
  17. Melting Point: 66-69 °C
  18. Boiling Point: 350.8 °C at 760 mmHg
  19. Flash Point: 166 °C
  20. Appearance: white crystalline powder
  21. Hazard Symbols:Xn,T,F
  22. Risk Codes: 22-39/23/24/25-23/24/25-11
  23. Safety: 22-26-36-45-36/37-16-7
  24. Transport Information: UN 3249
  25. WGK Germany:3
  26. Storage: Store at RT
  27. Usage : Topically used to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.
Add Comment
Please, Sign In to add comment